UA113840C2 - METHOD OF OBTAINING A SELECTED THERAPEUTIC RECOMBINANT BIOLOGICAL POLYPEPTIDE - Google Patents

METHOD OF OBTAINING A SELECTED THERAPEUTIC RECOMBINANT BIOLOGICAL POLYPEPTIDE

Info

Publication number
UA113840C2
UA113840C2 UAA201309671A UAA201309671A UA113840C2 UA 113840 C2 UA113840 C2 UA 113840C2 UA A201309671 A UAA201309671 A UA A201309671A UA A201309671 A UAA201309671 A UA A201309671A UA 113840 C2 UA113840 C2 UA 113840C2
Authority
UA
Ukraine
Prior art keywords
polypeptide
therapeutic recombinant
obtaining
selected therapeutic
recombinant biological
Prior art date
Application number
UAA201309671A
Other languages
Ukrainian (uk)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/020084 external-priority patent/WO2012094321A1/en
Publication of UA113840C2 publication Critical patent/UA113840C2/en

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Винахід стосується одержання виділеного терапевтичного рекомбінантного біологічного поліпептиду або білка для лікування захворювання, який включає трансфікування штучно одержаної плюріпотентної стовбурової клітини (spPSC) нуклеїновою кислотою, яка кодує вказаний терапевтичний рекомбінантний біологічний поліпептид або білок, експресію та виділення вказаного поліпептиду або білка з вказаної spPSC, де вказана spPSC одержана з клітини тварини.The invention relates to the production of a selected therapeutic recombinant biological polypeptide or protein for the treatment of a disease, which includes transfection of artificially obtained pluripotent stem cell (spPSC) with a nucleic acid that encodes a specified therapeutic recombinant polypeptide or polypeptide indicated polypeptide said spPSC is derived from an animal cell.

UAA201309671A 2011-01-03 2012-01-03 METHOD OF OBTAINING A SELECTED THERAPEUTIC RECOMBINANT BIOLOGICAL POLYPEPTIDE UA113840C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161429409P 2011-01-03 2011-01-03
PCT/US2012/020084 WO2012094321A1 (en) 2011-01-03 2012-01-03 Personalized production of biologics and method for reprogramming somatic cells

Publications (1)

Publication Number Publication Date
UA113840C2 true UA113840C2 (en) 2017-03-27

Family

ID=58531222

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201309671A UA113840C2 (en) 2011-01-03 2012-01-03 METHOD OF OBTAINING A SELECTED THERAPEUTIC RECOMBINANT BIOLOGICAL POLYPEPTIDE

Country Status (1)

Country Link
UA (1) UA113840C2 (en)

Similar Documents

Publication Publication Date Title
CY1119283T1 (en) GENETICALLY MODIFIED MOUSE EXPRESSIONS CHEMICAL MAJOR COMPLIANCE COMPLIANCE (MHC) II
EA201791633A1 (en) METHOD OF PRECISE MODIFICATION OF A PLANT BY MEANS OF TRANSIENT EXPRESSION OF THE GENE
EA201991255A1 (en) ADJUSTABLE TRANSCRIPTION
EA201792420A1 (en) COMPOSITIONS AND METHODS OF TCR REPROGRAMMING BY MEANS OF HYBRID PROTEINS
CL2013003028A1 (en) Interfering ribonucleic acid that represses the expression of target genes in insect species, isolated polynucleotide encoding it, DNA construct, host cell, composition comprising the interfering ribonucleic acid; and method to decrease the expression of a target gene in insect pests.
EA201390689A1 (en) PROSTATE ANTIGENS, NUCLEIC ACID MOLECULE, ENCODING THEM AND VACCINE, AND USE INCLUDING THEM
TR201803560T4 (en) Preparation methods of plant derived proteins.
EA200801074A1 (en) METHODS OF OBTAINING ARTIFICIAL HYBRID SEEDS
EA201391019A1 (en) CONNECTIONS AND METHODS FOR KINAZ MODULATION AND ALSO THE INDICATIONS TO THEIR APPLICATION
BR112015019879A2 (en) SPECIES COMPOSITIONS OF MODULATED LYSINE VARIANTS AND METHODS FOR THE PRODUCTION AND USE OF THEM
DK2831241T3 (en) ARTIFICIAL NUCLEIC ACID MOLECULES FOR IMPROVED PROTEIN OR PEPTIDE EXPRESSION.
EA201591131A1 (en) DNA STRUCTURE ANTIBODY AND METHOD OF THEIR APPLICATION
MX346923B (en) Genes and proteins for alkanoyl-coa synthesis.
BR112016011003A2 (en) genetically modified rodent animal, mouse embryonic stem cell, mouse embryo, and methods for making a rodent animal and grafting human cells into a mouse
EA201492202A1 (en) METHOD OF EXPRESSION OF HETEROLOGICAL PROTEINS USING A RECOMBINANT VIRAL VECTOR WITH RNA MINUS THREAD
MX368142B (en) Novel cloning, expression & purification method for the preparation of ranibizumab.
MX2016009848A (en) Method for controlling galactosylation of recombinant protein through optimization of culture medium.
EA201591251A1 (en) CHARACTERIZATION OF THE MEDICINE PRODUCT RELATED TO GLETIRAMER ACETATE
MX2020004803A (en) Humanized dipeptidyl peptidase iv (dpp4) animals.
EA201300130A1 (en) METHOD OF TREATMENT OF ALZHEIMER'S DISEASE
AR092152A1 (en) USE OF A CORN TRANSLATED REGION FOR TRANSGENIC EXPRESSION IN PLANTS
SG11201707858TA (en) Human serum albumin-containing culture medium for growth of neural stem cells
FI20115328A0 (en) New cutinases, their production and uses
PH12016502024B1 (en) Tonoplast proton/sugar antiporter proteins and the use thereof to increase the saccharose concentration in a saccharose storage organ of plants
WO2012122334A3 (en) Procollagen carboxy-terminal propeptides as a target and treatment for angiogenesis related diseases